New York Cancer & Blood Specialists

The Bronx, New York 10469

0 studies enrolling now · 4 studies all time

What they study most

Advanced Unresectable or Metastatic Solid Malignancy, Large B-Cell Lymphoma, Metastatic Castrate Resistant Prostate Cancer (mCRPC), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), Paroxysmal Nocturnal Hemoglobinuria

Studies at this site

• An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma — Running, not enrolling
• A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response — Completed
• The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC — Completed
• Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) — Completed